Michael Aberman

Michael Aberman is a seasoned biotech executive and entrepreneur with over 20 years of experience in the industry.12 He is currently the General Partner at Regeneron Ventures, a position he has held since April 2024.1 Prior to this, Aberman was the Founder and CEO of a Stealth Mode Startup in Biotech.

Aberman's career highlights include:

1. President and CEO of Quentis Therapeutics from September 2017 to December 2019.13
2. Senior Vice President of Strategy and Investor Relations at Regeneron Pharmaceuticals for over 7 years.1
3. Biotech Analyst at Credit Suisse for 4 years.1
4. Senior Director of Business Development at Antigenics.12

His educational background includes:

• BA in Biology from Cornell University (1989-1993)1
• MD from the University of Toronto (1993-1997)1
• MBA in Healthcare from The Wharton School (2000-2001)1

Aberman also serves on the boards of several biotech companies, including XenImmune Therapeutics and Unnatural Products.1 His expertise spans strategic planning, business development, financing, and corporate leadership in the biotechnology sector.12